2Huang F, Gu J, Zhao W, et al. One-year open-hbel trial of thalidomide in ankylosing spondylitis. Arthritis Rheum (Arthritis Care Res), 2002,47: 249-254.
3Davis J, Huang F, Maksymowych WP. New therapies for ankylosing spondylitis: etanercept, thalidomide and pamidronate. Rheum Dis Clin North Am, 2003,29 : 501-517.
4Huang F, Wei J, Breban M. Thalidomide in ankylosing spondylitis.Clin Exp Rheumatol, 2002,20: S158-161.
5Huang F, Gu J, Zhao W, et al. Therapeutic effect and molecular targets of thalidomide in refractory ankylosing spondylitis. Arthritis Rheum,2001,44 : S275.
6Gorman J, Sack K, Davis J. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. N Engl J Med, 2002,346:1349-1356.
7Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet, 2002,359:1187.
8Antoni C,Bmun J. Side effects of anti-TNF therapy: current knowledge. Clin Exp Rheumatol, 2002,20: S152-157.
